National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ulanqab Center for Disease Control and Prevention, Ulanqab, China.
Ann Med. 2022 Dec;54(1):1859-1866. doi: 10.1080/07853890.2022.2092894.
Brucellosis is a severe public health problem in China. However, analysis on related infection events is lacking. We performed a systematic analysis of brucellosis laboratory infection and vaccine infection events from 2006 to 2019 in China based on the published literatures. Our analysis showed that most laboratoryinfections in hospitals were found in Southern China. The identification and handling of suspected samples ofinfection without following the recommended biosafety protection was the main risk factor. It is important to strengthen the preventive awareness of clinical laboratory staff and physicians, while highlighting the compulsory handling and identification of suspected-infected samples in biosafety facilities and following biosafety practices. However, a severe infection accident at the Northeast Agricultural University, with 28 positive cases, showed that strengthening the management in teaching experiments of students in the veterinary-related profession is essential. However, cluster S2 vaccine strain infection events caused by vaccination and production were mainly observed in Northern China. Strengthening vaccination skills, personal protection, and improving the biosafety management of vaccine production and implementing regular risk surveillance is mandatory. Our analysis provides helpful clues for control of public health events involving brucellosis, as well as implementing intervention strategies is urgent.
布鲁氏菌病在中国是一个严重的公共卫生问题。然而,缺乏相关感染事件的分析。我们基于已发表的文献,对 2006 年至 2019 年中国布鲁氏菌病实验室感染和疫苗感染事件进行了系统分析。我们的分析表明,医院的大多数实验室感染发生在中国南方。主要的风险因素是在未遵循推荐的生物安全保护措施的情况下,对疑似感染样本的鉴定和处理。加强临床实验室工作人员和医生的预防意识非常重要,同时要强调在生物安全设施中强制处理和鉴定疑似感染样本,并遵守生物安全实践。然而,东北农业大学发生的一起严重感染事故,有 28 例阳性病例,表明加强兽医相关专业学生教学实验管理至关重要。然而,疫苗接种和生产引起的群 S2 疫苗株感染事件主要发生在中国北方。必须加强接种技术、个人防护,改进疫苗生产的生物安全管理,并实施定期风险监测。我们的分析为控制布鲁氏菌病公共卫生事件提供了有价值的线索,实施干预策略迫在眉睫。